AN2 Therapeutics Inc. (ANTX)
NASDAQ: ANTX
· Real-Time Price · USD
1.10
0.05 (4.27%)
At close: Aug 15, 2025, 3:59 PM
1.11
0.78%
After-hours: Aug 15, 2025, 07:15 PM EDT
AN2 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 80K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 40K | n/a | 21K | 19K | 20K | 20K | 19K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | 40K | n/a | -21K | -19K | -20K | -20K | -19K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -7.22M | -11.54M | -8.6M | -14.01M | -15.88M | -18.3M | -18.82M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.33M | -7.63M | -7.59M | -6.93M | -5M | -2.05M |
Interest Income | 754K | 888K | n/a | n/a | n/a | 1.68M | n/a | n/a | n/a | n/a | 630K | 466K | 228K | 27K | 27K | 25K | 15K | 2K |
Pretax Income | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.54M | -6.94M | -5.01M | -2.05M |
Net Income | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -14.61M | -12.79M | -10.91M | -10.12M | -7.66M | -7.54M | -6.94M | -5.01M | -2.05M |
Selling & General & Admin | 4.02M | 3.85M | 3.21M | 3.48M | 3.73M | 3.64M | 3.9M | 3.75M | 3.06M | 4.05M | 3.72M | 3.34M | 3.63M | 2.05M | 1.78M | 1.59M | 898K | 401K |
Research & Development | 3.2M | 7.69M | 5.4M | 8.29M | 12.15M | 14.65M | 14.92M | 14.43M | 13.54M | 11.98M | 8.75M | 8.43M | 6.7M | 5.63M | 5.81M | 5.34M | 4.1M | 1.65M |
Other Expenses | n/a | n/a | -9K | 2.24M | n/a | n/a | n/a | n/a | n/a | n/a | 4K | -35K | -15K | 1K | 22K | -36K | -24K | n/a |
Operating Expenses | 7.22M | 11.54M | 8.6M | 14.01M | 15.88M | 18.3M | 18.82M | 18.18M | 16.6M | 16.04M | 12.48M | 11.77M | 10.33M | 7.68M | 7.59M | 6.93M | 5M | 2.05M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 716K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | 2K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.22M | 11.54M | 8.6M | 14.01M | 15.88M | 18.3M | 18.82M | 18.18M | 16.6M | 16.04M | 12.48M | 11.77M | 10.33M | 7.68M | 7.59M | 6.93M | 5M | 2.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -18.82K | -18.18K | -21K | -716K | 945K | -431K | n/a | -55K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
Shares Outstanding (Diluted) | 30.17M | 30.05M | 29.88M | 29.84M | 29.82M | 29.76M | 29.73M | 25.64M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
EPS (Basic) | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.4 | -0.42 | -0.63 | -0.49 | -0.2 |
EPS (Diluted) | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.4 | -0.42 | -0.63 | -0.49 | -0.2 |
EBITDA | -7.22M | -11.54M | -7.52M | -11.77M | -15.88M | -15.06M | -16.9M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.33M | -7.68M | -7.59M | -6.93M | -5M | -2.05M |
EBIT | -6.46M | -11.54M | -7.52M | -11.77M | -15.88M | -16.62M | -16.9M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.12M | -7.66M | -7.59M | -6.93M | -5M | -2.05M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 25.41M | 18.3M | n/a | 18.18M | 21K | 19K | 20K | 20K | 19K | 7.68M | 7.59M | 6.93M | n/a | n/a |